In a ceremonial inaugural lecture in November 2025, Johanna Waidhauser was appointed as a Privatdozent by the Dean of the Faculty of Medicine at the University of Augsburg, Prof. Kadmon. The subject of her habilitation thesis is the characterisation of the cellular immune system in patients with solid neoplasms. Congratulations!
Phillip Löhr’s doctoral thesis, on changes in the cellular immune system during the acute phase of SARS-CoV-2 (COVID-19) at the University of Augsburg, and Pia Nerlinger on the topic of the correlation between the cellular immune status in peripheral blood and tissue-infiltrating lymphocytes in the primary tumour and regional lymph nodes in patients with colon cancer at Ludwig Maximilian University in Munich, and may now use the title of Doctor.
At the European Haematology Association Congress in Milan, Sven Richter presented our data on CXCR4 expression on leukaemic blasts in AML (CXCR4 Expression on Leukaemic Blasts of AML Patients in Peripheral Blood and Bone Marrow: Impact of Cryopreservation and Genetic Correlations, EHA 2025, Abstract 3573). At the annual congress of the German Society for Haematology and Oncology in October 2025, Phillip Löhr presented our findings on the influence of epigenetic agents in the treatment of acute myeloid leukaemia (Distinct T-Cell Population Dynamics During Treatment with Hypomethylating Agents and Venetoclax in Acute Myeloid Leukaemia Patients, Abstract P923). Johanna Waidhauser also presented interim results from our interdisciplinary SARIFA study at DGHO 2025 (NK Cells and SARIFA – Chicken or Egg?, Abstract P872).
